List of Tables
Table 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Targeted biologic therapies
Table 3. Key Players of Novel therapies
Table 4. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2019-2024)
Table 8. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2025-2030)
Table 10. Immune-Mediated Inflammatory Diseases Treatment Market Trends
Table 11. Immune-Mediated Inflammatory Diseases Treatment Market Drivers
Table 12. Immune-Mediated Inflammatory Diseases Treatment Market Challenges
Table 13. Immune-Mediated Inflammatory Diseases Treatment Market Restraints
Table 14. Global Immune-Mediated Inflammatory Diseases Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players (2019-2024)
Table 16. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2023)
Table 17. Ranking of Global Top Immune-Mediated Inflammatory Diseases Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Immune-Mediated Inflammatory Diseases Treatment Product Solution and Service
Table 21. Date of Enter into Immune-Mediated Inflammatory Diseases Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Immune-Mediated Inflammatory Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Immune-Mediated Inflammatory Diseases Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Immune-Mediated Inflammatory Diseases Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. GlaxoSmithKline Company Detail
Table 47. GlaxoSmithKline Business Overview
Table 48. GlaxoSmithKline Immune-Mediated Inflammatory Diseases Treatment Product
Table 49. GlaxoSmithKline Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024) & (US$ Million)
Table 50. GlaxoSmithKline Recent Development
Table 51. Eli Lilly Company Detail
Table 52. Eli Lilly Business Overview
Table 53. Eli Lilly Immune-Mediated Inflammatory Diseases Treatment Product
Table 54. Eli Lilly Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024) & (US$ Million)
Table 55. Eli Lilly Recent Development
Table 56. AstraZeneca Company Detail
Table 57. AstraZeneca Business Overview
Table 58. AstraZeneca Immune-Mediated Inflammatory Diseases Treatment Product
Table 59. AstraZeneca Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024) & (US$ Million)
Table 60. AstraZeneca Recent Development
Table 61. Bristol-Myers Company Detail
Table 62. Bristol-Myers Business Overview
Table 63. Bristol-Myers Immune-Mediated Inflammatory Diseases Treatment Product
Table 64. Bristol-Myers Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024) & (US$ Million)
Table 65. Bristol-Myers Recent Development
Table 66. Sanofi Company Detail
Table 67. Sanofi Business Overview
Table 68. Sanofi Immune-Mediated Inflammatory Diseases Treatment Product
Table 69. Sanofi Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Roche Company Detail
Table 72. Roche Business Overview
Table 73. Roche Immune-Mediated Inflammatory Diseases Treatment Product
Table 74. Roche Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024) & (US$ Million)
Table 75. Roche Recent Development
Table 76. Enlivex Therapeutics Company Detail
Table 77. Enlivex Therapeutics Business Overview
Table 78. Enlivex Therapeutics Immune-Mediated Inflammatory Diseases Treatment Product
Table 79. Enlivex Therapeutics Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024) & (US$ Million)
Table 80. Enlivex Therapeutics Recent Development
Table 81. Immune Pharmaceuticals Company Detail
Table 82. Immune Pharmaceuticals Business Overview
Table 83. Immune Pharmaceuticals Immune-Mediated Inflammatory Diseases Treatment Product
Table 84. Immune Pharmaceuticals Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024) & (US$ Million)
Table 85. Immune Pharmaceuticals Recent Development
Table 86. Tanabe Pharma Company Detail
Table 87. Tanabe Pharma Business Overview
Table 88. Tanabe Pharma Immune-Mediated Inflammatory Diseases Treatment Product
Table 89. Tanabe Pharma Revenue in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024) & (US$ Million)
Table 90. Tanabe Pharma Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Type: 2023 VS 2030
Figure 3. Targeted biologic therapies Features
Figure 4. Novel therapies Features
Figure 5. Global Immune-Mediated Inflammatory Diseases Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Pharmacy Store Case Studies
Figure 9. Online Pharmacy Stroe Case Studies
Figure 10. Immune-Mediated Inflammatory Diseases Treatment Report Years Considered
Figure 11. Global Immune-Mediated Inflammatory Diseases Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Immune-Mediated Inflammatory Diseases Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Immune-Mediated Inflammatory Diseases Treatment Market Share by Players in 2023
Figure 15. Global Top Immune-Mediated Inflammatory Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune-Mediated Inflammatory Diseases Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Immune-Mediated Inflammatory Diseases Treatment Revenue in 2023
Figure 17. North America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2019-2030)
Figure 19. United States Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2019-2030)
Figure 23. Germany Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Immune-Mediated Inflammatory Diseases Treatment Market Share by Region (2019-2030)
Figure 31. China Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Immune-Mediated Inflammatory Diseases Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Immune-Mediated Inflammatory Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
Figure 46. Eli Lilly Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
Figure 47. AstraZeneca Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
Figure 48. Bristol-Myers Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
Figure 50. Roche Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
Figure 51. Enlivex Therapeutics Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
Figure 52. Immune Pharmaceuticals Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
Figure 53. Tanabe Pharma Revenue Growth Rate in Immune-Mediated Inflammatory Diseases Treatment Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed